Health Care & Life Sciences » Pharmaceuticals | Daewon Pharmaceutical Co. Ltd.

Daewon Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Daewon Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Low Priced Stock Fund
1,871,384
9.8%
-1
0.1%
04/30/2018
Fidelity Funds SICAV - Asian Smaller Companies Fund
476,135
2.49%
-14,031
1.05%
05/31/2018
Fidelity Asian Values Plc
209,619
1.1%
0
1%
05/31/2018
DFA Emerging Markets Small Cap Series
117,734
0.62%
0
0.03%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
109,188
0.56%
13,289
0.01%
04/30/2018
CREF Stock Account
94,387
0.49%
0
0%
03/31/2018
Government Pension Fund - Global (The)
51,995
0.27%
-16,560
0%
12/31/2017
RAM (Lux) Systematic Funds - Emerging Markets Equities
48,147
0.25%
48,147
0.03%
06/30/2017
32,216
0.17%
0
0.3%
04/30/2018
Mirae Asset TIGER Health Care ETF
23,276
0.12%
5,475
0.28%
04/30/2018

About Daewon Pharmaceutical Co.

View Profile
Address
386 Cheonho-daero
Seoul SL 04808
Korea, Republic Of
Employees -
Website http://www.daewonpharm.com
Updated 07/08/2019
Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. It offers multivitamins, antipyretics, analgesics and antiinflammatory, gastrointestinal, endocrine, antimicrobial, psychoneurotic, respiratory, cardiovascular and neuromuscular drugs. The company was founded by Baek Boo-Hyeon on August 9, 1961 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.